The company said, “The Company is not aware of any material developments or changes to its operating or financial condition that precipitated the volume and price movements that occurred on July 15, 2025. There have been no material adverse changes to the company’s operating results, its business, strategy, or prospects other than what has been disclosed publicly by the Company to date, including an amendment to the Exchange Agreement with FITTERS Diversified Berhad announced on July 7, 2025.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYCC:
- Cyclacel Pharmaceuticals Amends Exchange Agreement with FITTERS
- Cyclacel announces amendment to exchange agreement with Fitters
- Cyclacel announces publication of preclinical data on plogosertib
- Upcoming Stock Splits This Week (July 7 to July 11) – Stay Invested
- Cyclacel Pharmaceuticals trading halted, news pending